Some research based on microarray analysis has demonstrated that CHMP4A could act as prognostic biomarkers and druggable targets for various diseases, including hepatocellular carcinoma, colorectal cancer, and ovarian carcinoma (55–57). The gene discussed is CHMP4A; the disease is ovarian carcinoma.